EPISODE · Nov 5, 2018 · 12 MIN
CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT) - Nov '18 update
from Stock Day Media · host Stock Day Media
CEO Dr. Carl Schwartz and Richard Gabriel of Precision Therapeutics Inc. (NASDAQ: AIPT), join the show to talk in detail about the state of the recent merger, new technology for tumor and cancer testing, and plans for 2019. NASDAQ: AIPT # formerly Skyline Medical: SKLN # FDA-approved STREAMWAY® System # Helomics Corporation # Direct to drain system # automated # breast cancer # Cytopatch # D-chip #FDA cleared # Lung cancer # medical devices # Ovarian # patented # Precision Oncology # STREAMWAY® System # Tumor Genesis # Tumor treatments # waste fluid management Advertising Inquiries: https://redcircle.com/brandsPrivacy & Opt-Out: https://redcircle.com/privacy
What this episode covers
CEO Dr. Carl Schwartz and Richard Gabriel of Precision Therapeutics Inc. (NASDAQ: AIPT), join the show to talk in detail about the state of the recent merger, new technology for tumor and cancer testing, and plans for 2019. NASDAQ: AIPT # formerly Skyline Medical: SKLN # FDA-approved STREAMWAY® System # Helomics Corporation # Direct to drain system # automated # breast cancer # Cytopatch # D-chip #FDA cleared # Lung cancer # medical devices # Ovarian # patented # Precision Oncology # STREAMWAY® System # Tumor Genesis # Tumor treatments # waste fluid management Advertising Inquiries: https://redcircle.com/brands Privacy & Opt-Out: https://redcircle.com/privacy
NOW PLAYING
CEO Dr. Carl Schwartz of Precision Therapeutics Inc. (NASDAQ: AIPT) - Nov '18 update
No transcript for this episode yet
Similar Episodes
Sep 22, 2023 ·20m
Sep 22, 2023 ·20m
Sep 22, 2023 ·27m
Sep 22, 2023 ·14m
Sep 22, 2023 ·24m
Sep 22, 2023 ·22m